rs61737499

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000750.5(CHRNB4):​c.1124C>T​(p.Thr375Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000871 in 1,614,010 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 11 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 4 hom. )

Consequence

CHRNB4
NM_000750.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.05

Publications

13 publications found
Variant links:
Genes affected
CHRNB4 (HGNC:1964): (cholinergic receptor nicotinic beta 4 subunit) This gene is found within a conserved gene cluster and encodes one of the beta subunits of the nicotinic acetylcholine receptor (nAChRs) superfamily which form ligand-gated ion channels with a central pore that forms a cation channel. Neuronal nAChRs are pentameric structures that can be either homomeric or heteromeric, with heteromeric structures containing both alpha and beta subunits. Each subunit contains an extracellular amino terminus and four transmembrane domains. Nicotine is one of the agonists that binds to the receptor. Variants in this gene have been associated with nicotine dependence and lung cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2017]
CHRNB4 Gene-Disease associations (from GenCC):
  • lung cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057582557).
BP6
Variant 15-78629181-G-A is Benign according to our data. Variant chr15-78629181-G-A is described in ClinVar as Benign. ClinVar VariationId is 779904.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAdExome4 allele frequency = 0.00049 (716/1461774) while in subpopulation AFR AF = 0.0165 (551/33480). AF 95% confidence interval is 0.0153. There are 4 homozygotes in GnomAdExome4. There are 304 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 689 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNB4NM_000750.5 linkc.1124C>T p.Thr375Ile missense_variant Exon 5 of 6 ENST00000261751.8 NP_000741.1 P30926-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNB4ENST00000261751.8 linkc.1124C>T p.Thr375Ile missense_variant Exon 5 of 6 1 NM_000750.5 ENSP00000261751.3 P30926-1
CHRNB4ENST00000412074.6 linkc.359+1895C>T intron_variant Intron 4 of 4 1 ENSP00000416386.2 P30926-2
ENSG00000259555ENST00000821537.1 linkn.312+1616G>A intron_variant Intron 2 of 2
CHRNB4ENST00000559849.5 linkn.*1180C>T downstream_gene_variant 1 ENSP00000457404.1 H3BU02

Frequencies

GnomAD3 genomes
AF:
0.00450
AC:
684
AN:
152118
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00122
AC:
307
AN:
251032
AF XY:
0.000788
show subpopulations
Gnomad AFR exome
AF:
0.0165
Gnomad AMR exome
AF:
0.000926
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000617
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000490
AC:
716
AN:
1461774
Hom.:
4
Cov.:
31
AF XY:
0.000418
AC XY:
304
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.0165
AC:
551
AN:
33480
American (AMR)
AF:
0.00105
AC:
47
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111926
Other (OTH)
AF:
0.00106
AC:
64
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
49
97
146
194
243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00453
AC:
689
AN:
152236
Hom.:
11
Cov.:
32
AF XY:
0.00437
AC XY:
325
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0157
AC:
654
AN:
41552
American (AMR)
AF:
0.00118
AC:
18
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68014
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
31
62
94
125
156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00160
Hom.:
3
Bravo
AF:
0.00518
ESP6500AA
AF:
0.0164
AC:
72
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00152
AC:
185
EpiCase
AF:
0.000109
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 25, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
9.0
DANN
Benign
0.66
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.34
T
MetaRNN
Benign
0.0058
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.2
L
PhyloP100
1.1
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.49
N
REVEL
Benign
0.083
Sift
Benign
0.26
T
Sift4G
Benign
0.23
T
Polyphen
0.21
B
Vest4
0.24
MVP
0.79
MPC
0.33
ClinPred
0.0072
T
GERP RS
2.9
Varity_R
0.052
gMVP
0.19
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61737499; hg19: chr15-78921523; API